Fact CheckerSign in

NCT07670975Recruiting

Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)

Measurement of Basal Metabolism in Patients With Crohn's Disease and Ulcerative Colitis and Correlation With Disease Activity.

Source: ClinicalTrials.gov · Last updated 26 Jun 2026

Brief summary (registry, in English)

This multicenter prospective observational non-pharmacological study aims to evaluate resting energy expenditure (REE) in pediatric patients affected by inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. REE will be measured using indirect calorimetry and estimated using predictive equations. The study also aims to investigate the relationship between REE, disease activity, and dietary or pharmacological treatments. Clinical, laboratory, anthropometric, nutritional, and disease activity data will be collected during routine clinical follow-up at diagnosis, after induction therapy, and during follow-up visits.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
22 Jun 2026
Start date
1 May 2025
Primary completion date
Mar 2027
Lead sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
NCT number
NCT07670975

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 1 May 2025 to the primary completion date, Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Intestinal surgery within 6 weeks before the first evaluation
  • Parenteral or enteral nutrition within 6 weeks before the first evaluation

Other illness

  • Eating disorders or other chronic diseases associated with possible malabsorption

Who the study is looking for

  • Pediatric patients aged 6 to 17 years
  • New diagnosis of inflammatory bowel disease, including Crohn disease or ulcerative colitis, according to ECCO/ESPGHAN criteria
  • Written informed consent signed by parents or legal guardians

Age in the registry: 6 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pediatric Unit
Coordinator of this site? Confirm its status
AlessandriaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.